 Jackson Center, Pennsylvania--Newsfile Corp. - June 21, 2021 - Halberd Corporations OTC Pink: HALB proprietary technology enters stage 4 to address Alzheimers Disease and other potential diseases; eradicating the antibody-disease combination through radiofrequency waves or laser or other means. Currently, there is no known effective treatment for Alzheimers Disease which afflicts over 40 million people worldwide, equivalent to the combined population of the states of Florida and New York.The seven 7 stages in Halberds... 